Please Wait...

  • +91 22 2783 1455

  • Product background
    CLARITHROMYCIN

WARNING: CAUTION : PLEASE NOTE :
The content or product detailing is not intended to replace advice from your prescribing doctor or healthcare professional. Lavina Pharma is not responsible for such actions by consumers. For any further information about the product please contact +91 22 2783 1455 and we can provide you the details.

CLARITHROMYCIN TABLETS USP 500 MG

Clarithromycin is indicated in adults and children 12 years and older. (Adult only formulations, e.g., tablets, IV)

Clarithromycin Tablets are indicated for treatment of the following infections caused by susceptible organisms Indication include:

Lower respiratory tract infections for example: acute and chronic bronchitis, and pneumonia.

Upper respiratory tract infections for example: sinusitis and pharyngitis.

Clarithromycin is also indicated in skin and soft tissue infections of mild to moderate severity e.g., folliculitis, cellulitis, erysipelas.

Clarithromycin in the presence of acid suppression effected by omeprazole or lansoprazole is also indicated for the eradication of H. pylori in patients with duodenal ulcers.


COMPOSITION

Clarithromycin USP 500 mg

Excipients q.s

Titanium Dioxide BP

Method of administration: Oral as directed by physician.

SIDE EFFECT

The most frequent and common adverse reactions related to clarithromycin therapy for both adult and peadiatric populations are abdominal pain, diarrhoea, nausea, vomiting and taste perversion. These adverse reactions are usually mild in intensity and are consistent with the known safety profile of macrolide antibiotics.





PRECAUTION

The physician should not prescribe clarithromycin to pregnant women without carefully weighing the benefits against risk, particularly during the first three months of pregnancy.




PRESENTATION

Clarithromycin Tablet is available in Alu-Alu blister of 7 tablets.